Bio-Techne
TECH
#1542
Rank
$10.91 B
Marketcap
$69.42
Share price
1.49%
Change (1 day)
-5.44%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2023 (TTM): $1.14 B

According to Bio-Techne's latest financial reports the company's current revenue (TTM) is $1.14 B. In 2022 the company made a revenue of $1.11 B an increase over the years 2021 revenue that were of $1.02 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 2001 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$1.14 B2.25%
2022$1.11 B8.77%
2021$1.02 B28.86%
2020$0.79 B7.29%
2019$0.74 B9.24%
2018$0.68 B13.74%
2017$0.59 B13.49%
2016$0.52 B13.55%
2015$0.46 B13.86%
2014$0.40 B23.73%
2013$0.33 B5.68%
2012$0.31 B1.91%
2011$0.30 B12.44%
2010$0.27 B2.96%
2009$0.26 B-1.37%
2008$0.26 B12.46%
2007$0.23 B12.76%
2006$0.21 B10.73%
2005$0.19 B13.71%
2004$0.16 B9.61%
2003$0.15 B11.36%
2002$0.13 B12.99%
2001$0.12 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$42.85 B 3,642.97%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.49 B 1,602.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$67.95 B 5,834.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.89 B 1,986.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.96 B 71.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$12.8 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.67 B 133.30%๐Ÿ‡บ๐Ÿ‡ธ USA